bSens.STRIPs is a generic name used to refer to reactive strips with specific biochemical reagents that react with analytes from biological samples (blood, urine or others). Each reactive strip is developed to carry out a single analysis, one of the most classic examples of this technology being the glucometer, equipment used on a large scale to control glucose in diabetic patients.
The first product developed by Biosens is the bSens.INR, designed to determine the prothrombin time (INR) for monitoring anticoagulated patients and in urgent and emergency situations. In addition to this one, there are four other products on the company's roadmap, which use the bSens technological platform, but adjusted for different targets, all evaluated based on the demands of health professionals, namely:
bSens.LAC: Lactate dosage in patients with sepsis and high-performance sports;
bSens.SYPH: Determination of non-treponemal antibodies for monitoring syphilis treatment in pregnant women;
bSens.CARBA: Determination of antimicrobial resistance genes;
bSens.SMA: Determination of antibodies for diagnosis of spinal muscular atrophy.